🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: EC regimen

Found 281 matching trials

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

PHASE3

Retinoblastoma is a childhood cancer which affects the retina of the eye. T...

Status

Completed

Location

St. Jude Children's Research Hospital

Start Date

2005-04-07

Trial ID

NCT00186888

Treatments Being Tested

Enucleation Vincristine, Carboplatin Focal Therapies External Beam Radiation Vincristine and Topotecan Vincristine + Carboplatin + Etoposide vincristine, cyclophosphamide, and doxorubicin Vincristine, Carboplatin and Etoposide Periocular carboplatin G-CSF

A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

PHASE2

This study aims to evaluate the efficacy and safety of adebrelimab consolid...

Status

Recruiting

Location

Henan Cancer Hospital

Start Date

2026-07-17

Trial ID

NCT07559786

Treatments Being Tested

CCRT(Employed residual field irradiation(RFI))CCRT(Involved-Field Radiotherapy (IFRT))

Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

PHASE3

This study will investigate the efficacy and safety of a steroid avoidance ...

Status

Completed

Location

C.H.U. La Milétrie

Start Date

2007-04

Trial ID

NCT00413920

Treatments Being Tested

Enteric-coated mycophenolate sodium (EC-MPS)Prednisone

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

PHASE3

Study GO43104 is a Phase III, randomized, open-label, multicenter study of ...

Status

Active Not Recruiting

Location

Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

Start Date

2021-11-18

Trial ID

NCT05091567

Treatments Being Tested

Atezolizumab Lurbinectedin Carboplatin Etoposide

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with sta...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2014-09-26

Trial ID

NCT02194738

Treatments Being Tested

Biospecimen Collection Carboplatin Cisplatin Clinical Observation Computed Tomography Crizotinib Cytology Specimen Collection Procedure Echocardiography Test Erlotinib Gemcitabine Hydrochloride Nivolumab Paclitaxel Pembrolizumab Pemetrexed Pemetrexed Disodium Placebo Administration Positron Emission Tomography

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

PHASE1

The purpose of this study is to evaluate the safety, tolerability, pharmaco...

Status

Withdrawn

Location

Multiple Locations

Start Date

2025-05-14

Trial ID

NCT06719973

Treatments Being Tested

M9466 Carboplatin Etoposide Atezolizumab M9446 M9446 Carboplatin

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)

PHASE1

This is a study to investigate the potential clinical benefit of trilacicli...

Status

Completed

Location

Genesis Cancer Center

Start Date

2015-06-26

Trial ID

NCT02499770

Treatments Being Tested

Carboplatin Placebo Trilaciclib Etoposide

A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients

PHASE4

This study will assess whether a calcineurin inhibitor (CNI)-free regimen w...

Status

Completed

Location

Novartis Investigative Site

Start Date

2009-02-24

Trial ID

NCT00862979

Treatments Being Tested

Everolimus (EVR)cyclosporine A (CyA)tacrolimus (TAC)Enteric coated mycophenolate sodium (EC-MPS)mycophenolate mofetil (MMF)Corticosteroids

A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

PHASE2

The purpose of this study is to demonstrate that treatment with BMS-986012 ...

Status

Completed

Location

Local Institution - 0075

Start Date

2021-03-17

Trial ID

NCT04702880

Treatments Being Tested

BMS-986012 Carboplatin Etoposide Nivolumab

STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)

PHASE2

To determine whether the combination of gemcitabine/carboplatin with hydrox...

Status

Terminated

Location

Dorset County Hospital NHS Foundation Trust

Start Date

2017-03-14

Trial ID

NCT02722369

Treatments Being Tested

Gemcitabine Carboplatin Etoposide Hydroxychloroquine

Previous Next